Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Asbestos-related disease: screening and diagnosis.

Rodríguez Portal JA.

Adv Clin Chem. 2012;57:163-85. Review.

PMID:
22870590
[PubMed - indexed for MEDLINE]
2.

Current status of screening for malignant pleural mesothelioma.

Pass HI, Carbone M.

Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):97-104. doi: 10.1053/j.semtcvs.2009.06.007. Review.

PMID:
19822280
[PubMed - indexed for MEDLINE]
3.

Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study.

Hollevoet K, Van Cleemput J, Thimpont J, De Vuyst P, Bosquée L, Nackaerts K, Germonpré P, Vansteelandt S, Kishi Y, Delanghe JR, van Meerbeeck JP.

J Thorac Oncol. 2011 May;6(5):889-95. doi: 10.1097/JTO.0b013e31820db377.

PMID:
21358346
[PubMed - indexed for MEDLINE]
4.

Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma.

Pantazopoulos I, Boura P, Xanthos T, Syrigos K.

Eur Respir J. 2013 Mar;41(3):706-15. doi: 10.1183/09031936.00226111. Epub 2012 Jul 26. Review.

PMID:
22835614
[PubMed - indexed for MEDLINE]
Free Article
5.

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.

Hollevoet K, Nackaerts K, Thimpont J, Germonpré P, Bosquée L, De Vuyst P, Legrand C, Kellen E, Kishi Y, Delanghe JR, van Meerbeeck JP.

Am J Respir Crit Care Med. 2010 Mar 15;181(6):620-5. doi: 10.1164/rccm.200907-1020OC. Epub 2010 Jan 14.

PMID:
20075387
[PubMed - indexed for MEDLINE]
6.

Biomarkers for malignant pleural mesothelioma: current status.

Greillier L, Baas P, Welch JJ, Hasan B, Passioukov A.

Mol Diagn Ther. 2008;12(6):375-90. doi: 10.2165/1250444-200812060-00004. Review.

PMID:
19035624
[PubMed - indexed for MEDLINE]
7.

Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.

Hollevoet K, Nackaerts K, Gosselin R, De Wever W, Bosquée L, De Vuyst P, Germonpré P, Kellen E, Legrand C, Kishi Y, Delanghe JR, van Meerbeeck JP.

J Thorac Oncol. 2011 Nov;6(11):1930-7. doi: 10.1097/JTO.0b013e3182272294.

PMID:
21841505
[PubMed - indexed for MEDLINE]
8.

Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.

Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, Grégoire M, Porte H, Copin MC, Lassalle P.

Clin Cancer Res. 2007 May 15;13(10):2928-35.

PMID:
17504993
[PubMed - indexed for MEDLINE]
Free Article
9.

Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer.

Muley T, Dienemann H, Herth FJ, Thomas M, Meister M, Schneider J.

J Thorac Oncol. 2013 Jul;8(7):947-51. doi: 10.1097/JTO.0b013e31828f696b.

PMID:
23777840
[PubMed - indexed for MEDLINE]
10.

Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.

Creaney J, Yeoman D, Demelker Y, Segal A, Musk AW, Skates SJ, Robinson BW.

J Thorac Oncol. 2008 Aug;3(8):851-7. doi: 10.1097/JTO.0b013e318180477b.

PMID:
18670302
[PubMed - indexed for MEDLINE]
11.

Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers.

Maeda M, Hino O.

Pathol Int. 2006 Nov;56(11):649-54. Review.

PMID:
17040286
[PubMed - indexed for MEDLINE]
12.

[Other thoracic cancers. Malignant pleural mesothelioma: biology and diagnosis].

Scherpereel A, Grigoriu BD, Astoul P.

Rev Mal Respir. 2008 Oct;25(8 Pt 2):3S183-90. French.

PMID:
18971844
[PubMed - indexed for MEDLINE]
13.

Update on malignant pleural mesothelioma.

Campbell NP, Kindler HL.

Semin Respir Crit Care Med. 2011 Feb;32(1):102-10. doi: 10.1055/s-0031-1272874. Epub 2011 Apr 15. Review.

PMID:
21500129
[PubMed - indexed for MEDLINE]
14.

Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.

Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K.

Lung Cancer. 2008 Aug;61(2):235-43. doi: 10.1016/j.lungcan.2007.12.025. Epub 2008 Feb 20.

PMID:
18281122
[PubMed - indexed for MEDLINE]
15.

[New diagnostic markers for malignant pleural mesothelioma].

Grigoriu BD, Grégoire M, Chahine B, Scherpereel A.

Bull Cancer. 2008 Feb;95(2):177-84. doi: 10.1684/bdc.2008.0576. Review. French.

PMID:
18304902
[PubMed - indexed for MEDLINE]
16.

Serum and pleural fluid biomarkers for mesothelioma.

Creaney J, Robinson BW.

Curr Opin Pulm Med. 2009 Jul;15(4):366-70. doi: 10.1097/MCP.0b013e32832b98eb. Review.

PMID:
19417672
[PubMed - indexed for MEDLINE]
17.

Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.

Rodríguez Portal JA, Rodríguez Becerra E, Rodríguez Rodríguez D, Alfageme Michavila I, Quero Martínez A, Diego Roza C, León Jiménez A, Isidro Montes I, Cebollero Rivas P.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):646-50. doi: 10.1158/1055-9965.EPI-08-0422. Epub 2009 Feb 3.

PMID:
19190155
[PubMed - indexed for MEDLINE]
Free Article
18.

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.

Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J.

Ann Thorac Surg. 2008 Jan;85(1):265-72; discussion 272.

PMID:
18154821
[PubMed - indexed for MEDLINE]
19.

Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.

Iwahori K, Osaki T, Serada S, Fujimoto M, Suzuki H, Kishi Y, Yokoyama A, Hamada H, Fujii Y, Yamaguchi K, Hirashima T, Matsui K, Tachibana I, Nakamura Y, Kawase I, Naka T.

Lung Cancer. 2008 Oct;62(1):45-54. doi: 10.1016/j.lungcan.2008.02.012. Epub 2008 Apr 3.

PMID:
18394747
[PubMed - indexed for MEDLINE]
20.

Diagnostic biomarker of asbestos-related mesothelioma: example of translational research.

Okio H, Kazu S, Masahiro M.

Cancer Sci. 2007 Aug;98(8):1147-51. Epub 2007 May 25. Review.

PMID:
17532755
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk